Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06535945
PHASE4

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Sponsor: Rennes University Hospital

View on ClinicalTrials.gov

Summary

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2025-03-26

Completion Date

2028-04-26

Last Updated

2025-12-09

Healthy Volunteers

No

Interventions

DRUG

Albumin administration

when albumin serum concentration is at 30 g/L or below

Locations (8)

08_CHRU de Tours Hôpital Trousseau

Chambray-lès-Tours, France

03_APHP Hôpital Beaujon

Clichy, France

04_CHU de Lille Hôpital Huriez

Lille, France

05_HCL Hôpital de la Croix Rousse

Lyon, France

06_CHU de Montpellier Hôpital St Eloi

Montpellier, France

02_CHU de Bordeaux - Hôpital Haut Leveque

Pessac, France

01_CHU de Rennes Hôpital Pontchaillou

Rennes, France

09_APHP Hôpital Paul Brousse

Villejuif, France